AzTrials
AzTrials

Infant DevelopmentNCT06195358

Mobile Health Intervention for Infants in Guatemala (18-m Intervention)

A study testing Mobile Health (Smartphone) Application and Printed Caregiving Materials in people with Infant Development, run by Children's Hospital Los Angeles at 1 site in Guatemala.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Promoting optimal development for children at risk in low- and middle-income countries (LMICs) is an important global health priority. Supporting caregivers to provide nurturing care is an evidence-based strategy, however feasibility of scaling-up this supporting is limited by competing demands on health workers'… Read more about this study

Who is it for?
Ages Up to 4 weeksHealthy volunteers can take part
Conditions the study is for
Infant Development
What is being tested?
Mobile Health (Smartphone) Application and Printed Caregiving Materials
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
1 siteGuatemala
Study dates
25 Jan 2024to 21 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 4 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • first-time caregivers with an infant in the eligible age range (0-4 weeks)
  • infant from singleton birth
  • infant from full-term (> 37 weeks gestation) birth

Who cannot join

  • Presence of acute malnutrition/wasting or severe medical illness (heart disease, kidney disease, congenital abnormality) in the infant
  • medical need for supplementation of breastfeeding
  • caregiver not literate

Trial locations and contacts

1 site in 1 country.

Guatemala1 site
  • Wuqu' Kawoq/ Maya Health Alliance

    Chimaltenango, Departamento de Chimaltenango

Other trials in Guatemala

About this study

Official title: Mobile Health Intervention to Promote Positive Infant Health Outcomes in Guatemala

Promoting optimal development for children at risk in low- and middle-income countries (LMICs) is an important global health priority. Supporting caregivers to provide nurturing care is an evidence-based strategy, however feasibility of scaling-up this supporting is limited by competing demands on health workers' time. For infant development, mHealth technologies have the potential to solve this problem by providing tailored content directly to caregivers, involving and empowering them to promote infant development, promoting and facilitating interactions with health workers when areas of concern are identified and, therefore, expanding the reach of healthcare systems. Following a pilot feasibility study, this current study will examine the effectiveness of a caregiver-directed smartphone application to directly engage first-time caregivers in rural Guatemala and support early childhood development.

Read the detailed description

Rationale: According to recent estimates, nore than 40% of children under age 5 residing in low- and middle-income countries (LMICs)-250 million children in total-are at risk of not reaching their developmental potential due to living in environments with malnutrition, poverty, and lack of early stimulation. Mobile health (mHealth) technology represents an efficient strategy for scaling interventions to promote infant development.

Intervention: Individually-randomized controlled trial of mHealth application compared to paper caregiving materials. Length of intervention = 18 months.

Objectives and purpose: We will test the effectiveness of a smartphone application that will directly engage caregivers in providing nurturing care to at-risk infants. We will assess effectiveness of the mHealth application compared to paper caregiving materials by comparing group differences in Bayley scores after 18 months (primary outcome = language composite score).

Study population: first-time parents of newborn infants, newborn infants.

Being tested
Mobile Health (Smartphone) Application, Printed Caregiving Materials
Keywords
early childhood development, LMIC, Guatemala, mHealth, smartphone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile Health (Smartphone) ApplicationDevice

    The intervention arm will receive the smartphone application, which has been designed to engage primary caregivers directly in the active monitoring of their infants' development, and to provide tailored feedback and support for the provision of nurturing care. Study staff will make an initial home visit (less than an hour) to install the application on the caregiver phone and demonstrate use and collect baseline data. Subsequently, in the intervention arm, staff will make visits every 3 months (approximately 15 minutes duration) to assess functionality of the smartphone and answer questions/reinforce use.

  • Printed Caregiving MaterialsOther

    The control arm will receive printed caregiving materials. In the control arm, staff will make visits every 3 months (approximately 15 minutes duration) to ask if there are questions about the printed caregiving materials.

Study groups in NCT06195358
Study groupRoleWhat they receive
Control ArmActive comparatorThe control arm will receive printed caregiving materials.
Receives: Other: Printed Caregiving Materials
Intervention ArmExperimentalThe intervention arm will receive the smartphone application.
Receives: Device: Mobile Health (Smartphone) Application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference between study arms in Composite Language Score

    Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 47-153

    Measured: 18 months

Secondary outcomes (4)
  1. Difference between study arms in Composite Cognitive Score

    Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 55-145

    Measured: 18 months

  2. Difference between study arms in Composite Motor Score

    Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 46-154

    Measured: 18 months

  3. Change in the Home Observation for Measurement of the Environment Scale (HOME) Raw Score

    Raw score range 0-45, higher scores better

    Measured: Change from 0 to 18 months

  4. Change in the Nursing Child Assessment Satellite Training (NCAST) Feeding Scale Total Score

    Raw score, higher scores better

    Measured: Change from 0 to 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2024
  2. Study start25 Jan 2024
  3. Primary completion21 Aug 2026
  4. Study completion21 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06195358
Sponsor's protocol ID
CHLA-21-00168_18-month
Other IDs
R33HD107983
Status last verified
Sep 2026
First submitted
22 Dec 2023
Last updated
10 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the published results will be deposited in a publicly accessible data repository.

Questions about this trial

What is this clinical trial studying?

A study testing Mobile Health (Smartphone) Application and Printed Caregiving Materials in people with Infant Development, run by Children's Hospital Los Angeles at 1 site in Guatemala.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Guatemala. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference between study arms in Composite Language Score (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in